Close

Therapix Biosciences (TRPX) Reports Positive Data From Pre-clinical Studies for THX-160 for Treatment of Pain

July 17, 2018 8:33 AM EDT Send to a Friend
Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login